Literature DB >> 23011454

Development of Sanofi Pasteur tetravalent dengue vaccine.

Jean Lang1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23011454     DOI： 10.1590/s0036-46652012000700007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN： 0036-4665            Impact factor:   1.846


× No keyword cloud information.
  4 in total

Review 1.  Recent progress in dengue vaccine development.

Authors:  Jianchun Wei; Hui Chen; Jing An
Journal:  Virol Sin       Date:  2014-12-24       Impact factor: 4.327

Review 2.  Vaccines for viral hemorrhagic fevers--progress and shortcomings.

Authors:  Darryl Falzarano; Heinz Feldmann
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

3.  The role of the mosquito in a dengue human infection model.

Authors:  Christopher N Mores; Rebecca C Christofferson; Silas A Davidson
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

4.  Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles.

Authors:  Janet C Lindow; Anna P Durbin; Stephen S Whitehead; Kristen K Pierce; Marya P Carmolli; Beth D Kirkpatrick
Journal:  Vaccine       Date:  2013-06-02       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.